PAIN
Volume 138, Issue 2 , Pages 255-266 , 31 August 2008

Gabapentin in traumatic nerve injury pain: A randomized, double-blind, placebo-controlled, cross-over, multi-center study

  • Torsten E. Gordh

      Affiliations

    • Multidisciplinary Pain Center, Uppsala University Hospital, S-751 85 Uppsala, Sweden
    • ,
  • Audun Stubhaug

      Affiliations

    • Department of Anaesthesiology, University of Oslo, Rikshospitalet University Hospital, 0027 Oslo, Norway
    • ,
  • Troels S. Jensen

      Affiliations

    • Department of Neurology, Danish Pain Research Centre, Aarhus University Hospital, Aarhus Sygehus Noerrebrogaede 44, Aarhus 8000, Denmark
    • ,
  • Staffan Arnèr

      Affiliations

    • Pain Clinic, Department of Anaesthesiology, Karolinska University Hospital, Solna, S-171 76 Stockholm, Sweden
    • ,
  • Björn Biber

      Affiliations

    • Department of Anaestesiology, Umeå University Hospital S-901 85 Umeå, Sweden
    • Present address: Department of Anaesthesiology and Intensive Care Sahlgrenska University Hospital, S-413 45 Göteborg, Sweden.
    • ,
  • Jörgen Boivie

      Affiliations

    • Department of Neurology, Linköping University Hospital, S-581 85 Linköping, Sweden
    • ,
  • Clas Mannheimer

      Affiliations

    • Multidisciplinary Pain Center, Department of Medicine, Sahlgrenska University Hospital, Östra 41685 Göteborg, Sweden
    • ,
  • Jarkko Kalliomäki

      Affiliations

    • Department of Rehabilitation, Lund University Hospital S-221 85 Lund, Sweden
    • ,
  • Eija Kalso

      Affiliations

    • Pain Clinic, Department of Anaesthesiology and Intensive Care Medicine, Helsinki University Central Hospital, Haartmaninkatu 2A, 00029 HUS, Finland
    • Corresponding Author InformationCorresponding author. Tel.: +358 9 47175885; fax: +358 9 47175641.

Received 22 April 2007 ,Revised 23 November 2007 ,Accepted 17 December 2007.

References 

  1. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA. 1998;280:1831–1836
  2. Chesler EJ, Ritchie J, Kokayeff A, Lariviere WR, Wilson SG, Mogil JS. Genotype-dependence of gabapentin and pregabalin sensitivity: the pharmacogenetic mediation of analgesia is specific to the type of pain being inhibited. Pain. 2003;106:325–335
  3. Cruccu G, Anand P, Attal N, Garcia-Larrea L, Haanpää M, Jørum E, et al. FENS guidelines on neuropathic pain assessment. Eur J Neurol. 2004;11:153–162
  4. Dooley DJ, Donovan CM, Pugsley TA. Stimulus-dependent modulation of [3H]norepinephrine release from rat neocortical slices by gabapentin and pregabalin. J Pharmacol Exp Ther. 2000;295:1086–1093
  5. Dworkin RH, Corbin AE, Young JP, Sharma U, LaMoreaux L, Bockbrader H, et al. Pregabalin for the treatment of postherpetic neuralgia. Neurology. 2003;60:1274–1283
  6. Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, et al. Core outcome measures for chronic pain clinical trial: IMMPACT recommendations. Pain. 2005;113:9–19
  7. Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94:149–158
  8. Fink K, Dooley DJ, Meder WP, Suman-Chauhan N, Duffy S, Clusmann H, et al. Inhibition of neuronal Ca++-influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology. 2002;42:229–236
  9. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain. 2005;118:289–305
  10. Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R, Woodruff GN. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the α2δ-subunit of a calcium channel. J Biol Chem. 1996;271:5768–5776
  11. Hahn K, Arendt G, Braun JS, von Giesen H-J, Husstedt IW, Maschke M, et al. A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. J Neurol. 2004;251:1260–1266
  12. Jefferson JW. Benzodiazepines and anticonvulsants for social phobia (social anxiety disorder). J Clin Psychiatry. 2001;62:235–244
  13. Jensen MP, Karoly P. Self report scales and procedures for assessing pain in adults. In:  Turk DC,  Melzack R editor. Handbook of pain assessment. New York: Guilford press; 2001;p. 15–34
  14. Jones B, Kenward M. Design and analysis of cross-over trials. 2nd Ed.. Boca Raton: Chapman & Hall; 2003;
  15. Kalso E, Allan L, Dellemijn PLI, Faura CC, Ilias WK, Jensen TS, et al. Recommendations for using opioids in chronic non-cancer pain. Eur J Pain. 2003;7:381–386
  16. Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain. 2004;112–380
  17. Karlsten R, Gordh T. How do drugs relieve neurogenic pain?. Drugs Aging. 1997;5:398–412
  18. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006;367:1618–1625
  19. Levendoglu F, Ögun Ö, Özerbil Ö, Ögun TC, Ugurlu H. Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury. Spine. 2004;29:743–751
  20. Lesser H, Sharma U, LaMoreaux L, Poole RM. Pregabalin relieves symptoms of painful diabetic neuropathy. Neurology. 2004;63:2104–2110
  21. Meyer-Rosberg K, Kvarnström A, Kinnman E, Gordh T, Nordfors LO, Kristofferson A. Peripheral neuropathic pain – a multidimensional burden for patients. Eur J Pain. 2001;5:379–389
  22. Meyerson J, Thelin S, Gordh T, Karlsten R. The incidence of chronic post-sternotomy pain after cardiac surgery – a prospective study. Acta Anaesthesiol Scand. 2001;45:940–944
  23. Moulin DE, Iezzi A, Amireh R, Sharpe WK, Boyd D, Merskey H. Randomised trial of oral morphine for chronic non-cancer pain. Lancet. 1996;347:143–147
  24. Pande AC, Davidson JRT, Jefferson JW, Janney CA, Katzelnick DJ, Weisler RH, et al. Treatment of social phobia with gabapentin: a placebo controlled study. J Clin Psychopharmacol. 1999;19:341–348
  25. Pande AC, Crockett JG, Feltner DE, Janney CA, Smith WT, Weisler R, et al. Pregabalin in generalized anxiety dis: a placebo-controlled trial. Am J Psychiatry. 2003;160:533–540
  26. Rice ASC, Maton S. Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain. 2001;94:215–224
  27. Rickels K, Pollack MH, Feltner DE, Lydiard RB, Zimbroff DL, Bielski RJ, et al. Pregabalin for treatment of general anxiety disorder. A 4-week multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam. Arch Gen Psychiatry. 2005;62:1022–1030
  28. Rosenstock J, Tuchman M, LaMoreayx L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain. 2004;110:628–638
  29. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA. 1998;280:1837–1842
  30. Sabatowski R, Gálvez R, Cherry DA, Jacquot F, Vincent E, Maisonobe P, et al. Pregabalin reduces and improves sleep and mood disturbances in patients with pot-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain. 2004;109:26–35
  31. Serpell MG. Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain. 2002;99:557–566
  32. Sullivan M, Karlsson J. The Swedish SF-36 Health Survey III. Evaluation of criterion-based validity: results from normative population. J Clin Epidemiol. 1998;51:1005–1113
  33. Tiippana E, Nilsson E, Kalso E. Post-thoracotomy pain after thoracic epidural analgesia: a prospective follow-up study. Acta Anaesthesiol Scand. 2003;47:433–438
  34. Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–483
  35. Wheeler G. Gabapentin (Pfizer). Curr Opin Invest Drugs. 2002;3:470–477

PII: S0304-3959(07)00751-8

doi: 10.1016/j.pain.2007.12.011

PAIN
Volume 138, Issue 2 , Pages 255-266 , 31 August 2008

Article Tools

* Image Usage & Resolution